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Abstract
Identification of neural circuit changes contributing to behavioral plasticity has routinely been
conducted on candidates that were preselected based on past results. Here we present an unbiased
method for identifying experience-triggered circuit-level changes in neuronal ensembles. Using
rabies virus monosynaptic tracing we mapped cocaine-induced global input changes onto ventral
tegmental area (VTA) neurons. Cocaine increased rabies labeled inputs from the globus pallidus
externus (GPe), a basal ganglia nucleus previously not known to participate in behavioral plasticity
triggered by drugs of abuse. We demonstrated that cocaine increased GPe neuron activity, which
accounted for the increase in GPe labeling. Inhibition of GPe activity revealed its vital role in two
different forms of cocaine-triggered behavioral plasticity, at least in part via GPe-mediated
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disinhibition of VTA dopamine neuron activity. These results suggest that rabies-based unbiased
screening of changes in input populations can identify previously unappreciated circuit elements
that critically support behavioral adaptations.

Author Manuscript

Plasticity in neuronal circuits enables animals to adapt to an ever-changing environment.
However, the loci and nature of experience-dependent changes in circuit function that drive
adaptive and pathological behaviors remain largely unknown. While modern techniques such
as optogenetics1 and chemogenetics2 permit sequential screening of targeted elements in
circuits with complex input and output patterns, unbiased approaches are necessary to
identify new components that play critical roles in the behavioral changes of interest. One
such approach uses the expression of immediate early genes to identify the neuronal
ensembles activated by a defined experience3,4 but as currently utilized, this approach does
not reveal the connectivity of these ensembles. Brain imaging techniques such as fMRI or
PET also provide insights into unexpected experience-dependent macroscopic connectivity
changes but lack cellular resolution. Thus, there is a need for additional methods that
facilitate unbiased identification of circuit substrates of experience-dependent behavioral
changes. Here, we present evidence that the rabies virus-based monosynaptic tracing
technique facilitates screening of circuit elements that contribute to behavioral changes by
allowing whole-brain mapping of monosynaptic inputs5,6 to defined starter neuronal
populations and their input/output relationships7–9.

Author Manuscript

To test the utility of a rabies virus-based approach for screening of behaviorally relevant
experience-dependent circuit adaptations, we initially focused on the VTA, a circuit node
critical for a variety of experience-dependent behaviors10–12. The diverse array of inputs to
and input-output relationships of VTA dopamine (DA) and GABA cells have been
extensively elucidated using rabies virus methods5,7. As a robust trigger of experiencedependent plasticity we administered drugs of abuse focusing on cocaine, which elicits longlasting behavioral adaptations including locomotor sensitization (LMS) and conditioned
place preference (CPP). Our unbiased input screen revealed an unexpected critical role for
the GPe, which has been implicated in motor control13, habit formation14, and Parkinson’s
disease15 but ignored when studying addiction-related behaviors triggered by drugs of abuse.
Our findings provide proof of principle for the utility of this approach while implicating the
GPe as playing a vital function for the establishment of drug-evoked behavioral plasticity.

Screen for cocaine-induced input changes

Author Manuscript

Cocaine administration induces modification of synapses on VTA-DA and VTA-GABA
neurons16 but the identities of cells providing those inputs are largely unknown. To test
whether rabies virus monosynaptic tracing might reveal the identity of inputs altered by
cocaine, we first employed the rabies monosynaptic input tracing technique17, where
animals were given a single injection of cocaine (15 mg/kg) or saline one day prior to
injection of the rabies virus, RVdG (Fig. 1a). Unbiased analysis of the labeled input cells
from 22 different brain regions comprising >90% of long-range inputs to VTA-DA neurons
revealed that while the global maps were quantitatively similar, labeling proportionally

Nature. Author manuscript; available in PMC 2018 August 01.

Beier et al.

Page 3

Author Manuscript

increased or decreased in a small subset of regions in cocaine-treated animals, with inputs
from the GPe displaying the largest magnitude proportional change (Fig. 1b).
To determine if similar labeling changes occurred in response to different classes of abused
substances, as occurs with synaptic adaptations onto VTA-DA neurons16, we administered
single doses of amphetamine, morphine, nicotine, or the psychoactive but non-addictive
substance fluoxetine. The drugs of abuse increased labeling of GPe cells while fluoxetine
did not (Fig. 1c, Extended Data Fig. 1a). As previous work using rabies virus revealed that
VTA-DA and VTA-GABA neurons receive similar inputs7, we next used the GAD2-Cre
mouse driver line to test if cocaine induced similar changes in labeling of cells making
monosynaptic contacts onto midbrain GABA neurons in the VTA and the nearby substantia
nigra pars reticulata (SNr) (Fig. 1d). Cocaine again elicited a proportional increase in
labeling of GPe cells compared to saline injections (Fig. 1e).

Author Manuscript

Cocaine enhances GPe-PV neuron activity

Author Manuscript

The four brain regions exhibiting the largest drug-induced change in labeling were the GPe,
anterior cortex (Ant. Ctx.), medial habenula (MHb), and nucleus accumbens medial shell
(NAcMedS) (Fig. 1c, Extended Data Fig. 1a). While the latter three are sites previously
implicated in the behavioral adaptations caused by drugs of abuse11, the potential role of the
GPe has not been investigated. What does the increase in rabies virus labeling of GPe inputs
onto VTA-DA and GABA cells indicate about the effects of cocaine? To address this
question we used parvalbumin (PV)-Cre or PV-Flp mouse driver lines to specifically target
GPe-PV cells as the majority of rabies-labeled GPe cells making synapses onto VTA-DA
neurons co-stained with PV (305/367; Extended Data Fig. 1b). Visualization of axons of
GPe-PV neurons expressing a membrane tagged GFP demonstrated that these cells send
major projections to a range of brain regions including the forebrain and thalamus (Extended
Data Fig. 2a, b). Consistent with prior work18, the major GPe projection to the midbrain was
to the SNr, which contains mostly GABA neurons19, while DA neuron-containing nuclei
such as the substantia nigra pars compacta (SNc) or VTA received fewer inputs (Extended
Data Fig. 2c, d).

Author Manuscript

To determine if the cocaine-induced increase in rabies virus labeling of GPe cells reflected
an increase in the number of synaptic contacts, we injected AAV-FLExloxP-mGFP-2Asynaptophysin-mRuby, which labels putative presynaptic sites (Fig. 2a), into the GPe of PVCre mice and imaged ~1 month later after a cocaine or saline injection (Fig. 2b). The density
and volume of these puncta in the SNr were indistinguishable in saline versus cocainetreated animals (Fig. 2c, d), suggesting no change in synapse number occurred. Next, we
assessed potential changes in synapse strength since single doses of drugs of abuse can
enhance synaptic strength of both excitatory and inhibitory inputs into the ventral
midbrain16. We injected AAV-FLExFRT-ChR2 into the GPe of PV-Flp animals and
conducted whole-cell recordings from SNr neurons in acute slices ~1 month later. Calcium
in the extracellular recording solution was replaced by strontium to enable measurements of
quantal events20 (Fig. 2e, f). No change in the amplitude or frequency of quantal events was
observed in slices prepared from cocaine versus saline treated animals (Fig. 2g, h),
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suggesting cocaine did not elicit a change in the strength of the inhibitory synapses made by
GPe-PV neurons on SNr neurons.

Author Manuscript

Finally, we assessed if GPe-PV neuron spontaneous activity in vivo was altered by cocaine
by expressing the fluorescent Ca2+ indicator GCaMP6f in GPe-PV neurons and collecting
population Ca2+-dependent signals using fiber photometry (Fig. 2i). While cocaine
administration had no significant acute effect, population activity increased two-fold the
following day (Fig. 2j, k). To assess if this increase might reflect changes in intrinsic
excitability, we injected AAV-FLExloxP-GFP into the GPe of PV-Cre mice and made
targeted whole-cell current clamp recordings from acute GPe slices prepared one day after
animals received saline or cocaine injections (Fig. 2l). GPe-PV neurons from cocaine-treated
animals were more excitable in that more action potentials were generated by depolarizing
current injection steps (Fig. 2m, n) with no change in cells’ input resistances (Fig. 2n). These
results demonstrate that a single exposure to cocaine triggers increases in the spontaneous
activity and excitability of GPe-PV neurons.

Input activity modulates rabies labeling

Author Manuscript

Are the cocaine-induced changes in rabies virus labeling of GPe-PV input neurons due to
the observed changes in their activity? To address this possibility, we expressed transgenes
in GPe-PV neurons that permit manipulation of their activity levels while simultaneously
performing rabies virus transsynaptic labeling. Chronic activity manipulations bidirectionally influenced the extent of GPe neuronal labeling: chronic inhibition of GPe-PV
neuron activity with the inhibitory DREADD hM4Di2 or Kir2.121 decreased rabies virus
labeling of GPe neurons compared to control and YFP-expressing animals while the
excitatory manipulation using hM3Dq2, on average, increased labeling (Fig. 3d). As a
control for these manipulations, we examined labeling in the NAcMedS and found no effect
due to expressing any of these transgenes in GPe-PV neurons (Fig. 3e).

Author Manuscript

To determine if the effects of chronic activity changes on rabies virus transsynaptic labeling
generalized to other brain regions, we performed the same genetic manipulations on
NAcMedS-D1 receptor-expressing medium spiny neurons (MSNs), the labeling of which
was decreased by drugs of abuse (Fig. 1c; Extended Data Fig. 1a, c). Parallel to the effects of
manipulating GPe-PV neurons, chronic NAcMedS inhibition using hM4Di or Kir2.1 reduced
labeled inputs in the NAcMedS, while activation with hM3Dq enhanced NAcMedS labeling
(Fig. 3h). Unexpectedly, while NAcMedS inhibition did not alter labeling of GPe neurons,
NAcMedS activation increased labeled GPe inputs (Fig. 3g), suggesting that NAcMedS-D1
MSN activation indirectly increases GPe activity. Together, these experiments provide
evidence that rabies-mediated transsynaptic labeling from starter neurons is influenced by
the level of activity in input cell populations. Furthermore, they support the hypothesis that
cocaine as well as other drugs of abuse chronically increases the level of GPe-PV neuron
activity and this accounts for the observed increase in their labeling by the rabies virus.
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Behavioral changes require GPe activity

Author Manuscript

To determine if the cocaine-elicited changes in GPe-PV neuron activity revealed by rabies
virus tracing are functionally relevant and necessary for cocaine-induced behavioral
adaptations, we examined if inhibition of GPe-PV neurons influenced two forms of cocaineinduced behavioral plasticity, LMS and CPP. Inhibition of activity in GPe-PV neurons using
expression of any one of three different transgenes, hM4Di, Kir2.1, or the tetanus toxin light
chain (TeTxLc), which inhibits presynaptic vesicle release22, prevented cocaine-induced
LMS (Fig. 4a-c), while having no effect on basal locomotion and only a modest effect on
cocaine-induced locomotion upon initial administration (Extended Data Fig. 3).
Furthermore, there was a positive correlation between the number of rabies-labeled GPe
inputs and the magnitude of LMS in a two-day injection protocol for cocaine as well as
other addictive drugs (Extended Data Fig. 4). Similar results were obtained for cocaineelicited CPP: using a four-day protocol (Fig. 4d), inhibition of GPe-PV activity via
expression of hM4Di, Kir2.1, or TeTxLc prevented CPP (Fig. 4e, f). Inhibition of GPe-PV
neurons with hM4Di also prevented morphine-induced LMS and CPP (Extended Data Fig.
5), implying that the role of these neurons may generalize to other abused substances.

Author Manuscript

A limitation of these experiments is that GPe-PV neurons project to several different brain
regions (Extended Data Fig. 2) and thus the transgene-mediated inhibition of these neurons
was not target-specific. To limit expression of an inhibitory transgene specifically to those
GPe-PV neurons projecting to the midbrain, we injected a retrogradely-transported CAVFLExloxP-Flp into the midbrain of PV-Cre mice and a Flp-dependent AAV-FLExFRT-Kir2.1
into the GPe, enabling Kir2.1 expression only in Cre-expressing GPe-PV neurons projecting
to the midbrain (Extended Data Fig. 6a). This manipulation prevented both cocaine-elicited
LMS and CPP (Extended Data Fig. 6b, c). However, subsequent axon tracing experiments
revealed that the GPe-PV neurons projecting to the midbrain collateralize extensively
(Extended Data Fig. 7), limiting the interpretation of this experiment. To specifically inhibit
the GPe-PV neuron projections within the midbrain, we expressed hM4Di in GPe-PV
neurons and infused slow-release CNO microspheres23 into the midbrain (Fig. 4g). This
local inhibition was sufficient to block both cocaine-induced LMS (Fig. 4h) and CPP (Fig.
4i). After waiting a week to allow for depletion of CNO, these same animals were re-tested
using the same protocols, and expressed significant LMS and CPP (Fig. 4h, i). These results
demonstrate that activity in the projection of GPe-PV neurons to the midbrain is necessary
for two different forms of cocaine-induced behavioral plasticity.

GPe-PV neurons disinhibit VTA-DA neurons
Author Manuscript

Does the cocaine-induced increase in activity in inhibitory GPe-PV neurons influence DA
cell activity, which is required for induction of LMS and CPP (Extended Data Fig. 8)? Given
that the major projection from GPe-PV neurons to the midbrain is into the SNr (Extended
Data Fig. 2), a simple hypothesis is that GPe-PV neurons strongly inhibit SNr neurons that
tonically inhibit DA neurons. Thus, activation of GPe-PV neurons would increase DA
neuron activity via disinhibition despite some direct synaptic inhibition of DA cells. We
tested this hypothesis in several ways. First, to examine the functional strength of GPe-PV
neuron connections to midbrain DA and GABA neurons, we injected a Flp-dependent AAV
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expressing channelrhodopsin (AAV-FLExFRT-ChR2) into the GPe of either DAT-Cre;PV-Flp
or GAD2-Cre;PV-Flp double transgenic animals, AAV-FLExloxP-GFP into the VTA to label
DA or GABA neurons (Fig. 5a), and retrobeads into either the NAcMedS or nucleus
accumbens lateral shell (NAcLatS) to demarcate one of two VTA-DA subpopulations whose
inputs are modified by cocaine24. We then assayed monosynaptic inhibitory postsynaptic
currents (IPSCs) via whole-cell recordings in acute slices. Optical stimulation of GPe-PV
neuron axons evoked large IPSCs in the majority (63%, n=24) of SNr-GABA neurons (Fig.
5b-c). In the same sets of slices using the same optical stimulation, the connectivity onto
VTA neurons was much smaller (5-14%) as was the size of the IPSCs in cells in which they
could be detected (Fig. 5b, c, Extended Data Fig. 9). These results demonstrate that
functionally, GPe-PV neurons exhibit much stronger inhibitory connections onto SNrGABA neurons than VTA-DA or VTA-GABA neurons and thus the GPe-PV synapses in the
VTA appear to be of limited functional importance.

Author Manuscript

Second, we tested if manipulating activity in SNr-GABA neurons could impact the
development of LMS and CPP. Activating SNr-GABA neurons via hM3Dq prevented the
development of LMS and CPP (Extended Data Fig. 10a-c) while concurrently inhibiting
SNr-GABA neurons via hM4Di during chronic GPe-PV neuron inhibition rescued cocainemediated behavioral plasticity (Extended Data Fig. 10d-f). These results suggest that GPePV neuron inhibition prevents LMS and CPP by enhancing activity of SNr-GABA neurons.

Author Manuscript

Third, we examined if SNr-GABA neurons provide direct inhibition to DA neurons using a
modified rabies virus input tracing strategy25 to label local inputs onto DA neurons and
combining this with in-situ hybridization for GAD1/2 mRNA (Fig. 5d, e). Quantitatively,
SNr-GABA neurons were the second-largest source of inhibitory inputs to DA neurons (Fig.
5f).
Fourth, we tested if changes in GPe-PV neuron activity influenced integrated VTA-DA
neuron activity using Fos labeling. In YFP-expressing animals, acute cocaine administration
caused a clear increase in Fos+ DA neurons compared to saline injected animals measured
90 minutes after injection (Fig. 5j). Inhibition of GPe-PV neurons with hM4Di had no effect
in saline treated animals but completely prevented the increase in cocaine treated animals, as
did expression of Kir2.1 (Fig. 5j). Conversely, activation of GPe-PV neurons via ChR2
increased Fos expression in DA cells to a degree similar to that elicited by cocaine (Fig. 5j).

Author Manuscript

Finally, to directly test the effect of activating GPe-PV neurons on VTA-DA neuron activity
in vivo, we injected a Flp-dependent red-shifted opsin bReachES26 in the GPe and a Credependent GCaMP6f in the VTA of DAT-Cre;PV-Flp double transgenic mice and recorded
population activity from VTA-DA neurons with fiber photometry while optically activating
GPe-PV neurons (Fig. 5k). Stimulation of GPe-PV neurons caused a small but significant
increase of GCaMP6f fluorescence in VTA-DA neurons (Fig. 5l-m). Taken together, these
results indicate that GPe-PV neurons control VTA-DA neuron activity through a disynaptic
disinhibition via SNr-GABA neurons (Fig. 5n).
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Concluding remarks

Author Manuscript

Connecting specific experience-dependent circuit changes with corresponding behavioral
adaptations has been hampered by a lack of suitable methodology. While most investigations
of circuit function rely on a candidate approach leveraging the advantages of cell-type
specific manipulations, a limitation is the requirement of a priori assumptions regarding the
roles of targeted populations. Given the complexity of circuit mechanisms mediating animal
behaviors, unbiased approaches offer advantages for identifying the array of specific
neuroplastic changes that drive behavioral changes. Here, we demonstrate that neural
activity influences the extent of labeling by the rabies monosynaptic input-tracing method.
This property enabled identification of circuit elements that were modified by experience in
a behaviorally relevant manner. Specifically, the activity-dependence of rabies labeling
enabled the identification of an underappreciated circuit node, the GPe, as a central player in
cocaine-induced behavioral adaptations. As a core component of the dorsal striatal indirect
pathway implicated in motor control13 and associated disorders15,27, the GPe had not
previously been directly linked to addictive behaviors. Using a number of different assays,
we demonstrated that the effect of enhanced GPe input to the midbrain is increased VTA-DA
neuron activity via a mechanism of disinhibition (Fig. 5n). These findings provide a novel
circuit mechanism for influencing VTA-DA neuron activity, the critical role of which in
drug-induced behavioral adaptations11,28 we confirmed (Extended Data Fig. 8). Given that
the rabies virus transsynaptic technique has been used successfully to map inputs onto cell
populations in many brain areas5–9,29–32, we anticipate that this method will be
generalizable and complementary to other circuit analysis methods1, 2 for elucidating how
activity changes in connected ensembles orchestrate features of complex behaviors.

Author Manuscript

Methods
No statistical methods were used to predetermine sample size. Experiments described in
Figures 1, 2a-h and 2l-n, 3, 5g-j and Extended Data Figs. 1a, 4, 5, 6, 8, and 10 were
randomized and investigators were blinded to allocation and outcome assessments; all other
experiments were not randomized and investigators were not blinded.
Mice and Viral Procedures

Author Manuscript

Generation and characterization of the DAT-Cre34, GAD2-Cre35, PV-Cre36, PV-Flp37, A2aCre38, and D1-tdtomato39 mouse lines have been described previously. Mice were housed on
a 12-hour light/dark cycle with food and water ad libitum. Males and females from a mixed
CD1 and C57/BL6 background were used for all experiments in approximately equal
proportions. All surgeries were done under isoflurane anesthesia. All procedures complied
with the animal care standards set forth by the National Institute of Health and were
approved by Stanford University’s Administrative Panel on Laboratory Animal Care and
Administrative Panel of Biosafety.

pAAV-CAG-FLExloxP-G, pAAV-CAG-FLExloxP-TC, pAAV-CAG-FLExloxP-TC66T, pAAVCAG-FLExFRT-G, pAAV-CAG-FLExFRT-TC, and pCAV-FLExloxP-Flp were constructed as
reported previously8. For construction of viruses containing Kirr2.1-2A-GFP, hM4DimCherry, and hM3Dq-mCherry, pAAV-hSyn1-FLExloxP-mGFP-2A-synaptophysin-mRuby9
Nature. Author manuscript; available in PMC 2018 August 01.
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or pAAV-hSyn1-FLExFRT-mGFP-2A-synaptophysin-mRuby7 were used as templates. All
inserts were cloned into the AscI and SalI sites between the loxP or FRT sites. hM3DqmCherry or hM4Di-mCherry were PCR-amplified from pAAV-hSyn-DIO-hM3Dq-mCherry
or pAAV-hSyn-DIO-hM4Di-mCherry, respectively40, and Kir2.1-2A-GFP was modified
from Xue et al.41. AAV-CMV-FLExloxP-GFP-2A-TeTxLc, AAV-hSyn-FLExloxPChR2(H134R)-eYFP, AAV-hSyn-FLExloxP-eYFP, and AAV-hSyn-FLExFRT-eYFP were
purchased from the Stanford Gene and Viral Vector Core.
Transsynaptic tracing

Author Manuscript

Transsynaptic tracing studies were carried out as previously described7, with minor
modifications. For rabies tracing, 100 nL of a 1:1 volume mixture of AAV-CAG-FLExloxPTC and AAV-CAG-FLExloxP-G was injected into the VTA of 4-6 week-old mice. Thirteen
days later, a single dose of cocaine (15 mg/kg), amphetamine (10 mg/kg), nicotine (0.5 mg/
kg), morphine (10 mg/kg), fluoxetine (10 mg/kg), or saline was injected intraperitoneally
(IP), and the mouse was placed in a new cage for thirty minutes before being returned to its
home cage. The following day, RVdG was injected into the VTA. After recovery, mice were
housed in a BSL2 facility for 5 days to allow for rabies spread and GFP expression. P values
presented in Fig. 1 were not corrected for multiple comparisons.

Author Manuscript

For identification of local GABAergic inputs to VTA-DA neurons, 100 nL of a 1:1 volume
mixture of AAV-CAG-FLExloxP-TC66T and AAV-CAG-FLExloxP-G was injected into the
VTA of 4-6 week-old mice. Two weeks later, RVdG was injected into the VTA, and animals
were sacrificed five days later. For in-situ hybridization, midbrain sections were stained with
probes for Gad1 and Gad26, and imaged on a Zeiss LSM780 microscope at 20×
magnification. Imaging, histology, and whole-brain quantification were performed as
previously described7. In Fig. 5f, the VTA included the parabrachial pigmented area (PBP)
and paranigral nucleus (PN). Data were averaged from three animals.
Coordinates used were (relative to Bregma, midline, or dorsal brain surface and in mm):
VTA: AP −3.20, ML 0.4, DV −4.2
NAcLat: AP +1.45, ML 1.75, DV −4.0
NAcMed: AP +1.55, ML 0.7, DV −4.0
GPe: AP −0.35, ML 1.75, DV −3.5
SNr (midbrain): AP −3.2, ML 1.1, DV −4.5

Author Manuscript

Abbreviations for brain regions made throughout the paper are listed below, in alphabetical
order.
Ant. Ctx., anterior cortex
BNST, bed nucleus of the stria terminalis
CeA, central amygdala
DCN, deep cerebellar nuclei
DMStr, dorsomedial striatum
Nature. Author manuscript; available in PMC 2018 August 01.
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DR, dorsal raphe
DStr, dorsal striatum
EAM, extended amygdala
EP, entopeduncular nucleus
GPe, globus pallidus externus
IF, interfascicular nucleus
IPN, interpeduncular nucleus
LDT, laterodorsal tegmentum

Author Manuscript

LH, lateral hypothalamus
LHb, lateral habenula
MHb, medial habenula
mPFC, medial prefrontal cortex
mRT, midbrain reticular nucleus
NAcCore, nucleus accumbens core
NAcMedS, nucleus accumbens medial shell
NAcLatS, nucleus accumbens lateral shell
PBN, parabrachial nucleus

Author Manuscript

PO, preoptic nucleus
PRN, pontine reticular nucleus
PVH, paraventricular hypothalamus
SNc, substantia nigra pars compacta
SNr, substantia nigra pars reticulata
STN, subthalamic nucleus
VP, ventral pallidum
VTA, ventral tegmental area

Author Manuscript

ZI, zona incerta
The titers of viruses, based on quantitative PCR analysis, were as follows:

AAV-CAG-FLExloxP-TC, serotype 5, 2.4 × 1013 genome copies (gc)/mL;
AAV-CAG-FLExloxP-G, serotype 8, 1.0 × 1012 gc/mL;
AAV-CAG-FLExFRT-TC, serotype 5, 2.6 × 1012 gc/mL;
AAV-CAG-FLExFRT-G, serotype 8, 1.3 × 1012 gc/mL;
Nature. Author manuscript; available in PMC 2018 August 01.
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AAV-CAG-FLExloxP-TC66T, serotype 2, 1.0 × 1012 gc/mL;

Author Manuscript

AAV-hSyn-FLExloxP-mGFP-2A-synaptophysin-mRuby, serotype DJ, 9.3 × 1012
gc/mL;
AAV-hSyn-FLExloxP-hM3Dq-mCherry, serotype DJ, 4.0 × 1012gc/mL;
AAV-hSyn-FLExloxP-hM4Di-mCherry, serotype DJ, 5.5 × 1012 gc/mL;
AAV-hSyn-FLExloxP-Kir2.1-T2A-GFP, serotype DJ, 5.6 × 1013 gc/mL;
AAV-CMV-FLExloxP-eGFP-2A-TeTxLc, serotype DJ, 2.1 × 1012 gc/mL;
AAV-hSyn-FLExloxP-ChR2(H134R)-YFP, serotype DJ, 1.4 × 1013 gc/mL;
AAV-hSyn-FLExloxP-YFP, serotype DJ, 1.5 × 1013 gc/mL;

Author Manuscript

AAV-EF1α-FLExloxP-GCaMP6f, serotype 5, 1.9 × 1013 gc/mL;
AAV-hSyn-FLExFRT-mGFP-2A-synaptophysin-mRuby, serotype DJ, 3.7 × 1012
gc/mL;
AAV-hSyn-FLExFRT-hM4Di-mCherry, serotype DJ, 2.9 × 1013 gc/mL;
AAV-hSyn-FLExFRT-hM3Dq-mCherry, serotype DJ, 4.6 × 1013 gc/mL;
AAV-hSyn-FLExFRT-Kir2.1-T2A-GFP, serotype DJ, 7.2 × 1013 gc/mL;
AAV-hSyn-FLExFRT-ChR2(H134R)-YFP, serotype DJ, 5.2 × 1012 gc/mL;
AAV-hSyn-FLExFRT-YFP, serotype DJ, 4.3 × 1012 gc/mL;
AAV-EF1α-FLExFRT-bReachES-mCherry, serotype 5, 2.5 × 1013 gc/mL;
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AAV-hSyn-FLExOFFloxP-hM4Di-mCherry, serotype DJ, 1.1 × 1013 gc/mL;
AAV-hSyn-FLExOFFloxP-hM3Dq-mCherry, serotype DJ, 1.2 × 1013 gc/mL;
AAV-hSyn-FLExOFFloxP-Kir2.1-T2A-GFP, serotype DJ, 7.8 × 1012 gc/mL;
AAV-hSyn-FLExOFFloxP-YFP, serotype DJ, 1.4 × 1013 gc/mL;
CAV-FLExloxP-Flp, 5.0 × 1012 gc/mL;
RVdG, 5.0 × 108 colony forming units (cfu)/mL (both GFP and mCherry)
Rabies input tracing + targeted input activity manipulations

Author Manuscript

For tracing inputs from VTA-DA neurons while manipulating input regions, we used either
DAT-Cre;PV-Flp double heterozygotes (for GPe manipulations) or DAT-Cre;A2a-Cre double
heterozygotes (for NAcMedS manipulations) between 4-6 weeks of age.
To manipulate GPe-PV neurons, in DAT-Cre;PV-Flp mice, 100 nL of a 1:1 volume mixture
of AAV-CAG-FLExloxP-TC and AAV-CAG-FLExloxP-G was injected into the VTA of both
hemispheres, and 300 nL of AAV-FLExFRT-hM4Di, AAV-FLExFRT-hM3Dq, AAVFLExFRT-Kir2.1, or AAV-FLExFRT-YFP was injected into the GPe. Both hemispheres were
used for each animal, and counted independently. AAV-FLExFRT-hM4Di and AAVFLExFRT-hM3Dq were injected into the same animals, as were AAV-FLExFRT-Kir2.1 and
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AAV-FLExFRT-YFP. One month later, RVdG was injected bilaterally into the VTA. To
activate DREADDs, animals were injected once every 12 hours with CNO for five days
beginning immediately after RVdG injection.
To manipulate NAcMedS-D1 neurons, in DAT-Cre;A2a-Cre mice, 100 nL of a 1:1 volume
mixture of AAV-FLExloxP-TC and AAV-FLExloxP-G was injected into the VTA of both
hemispheres, and 300 nL of either AAV- FLExOFFloxP-hM4Di, AAV- FLExOFFloxPhM3Dq, AAV- FLExOFFloxP-Kir2.1, or AAV-FLExOFFloxP-YFP was injected into the
NAcMedS. Both hemispheres were used for each animal, and counted independently. AAVFLExOFFloxP-hM4Di and AAV-FLExOFFloxP-hM3Dq were injected into the same animals,
as were AAV-FLExOFFloxP-Kir2.1 and AAV-FLExOFFloxP-YFP. One month later, RVdG
was injected bilaterally into the VTA.

Author Manuscript

For both GPe and NAcMedS manipulations, in animals injected with hM4Di-mCherry or
hM3Dq-mCherry, an RVdG that expressed GFP was used; if the AAV expressed GFP or
YFP, RVdG expressing mCherry was used.
Due to the large sample sizes of the experiments involving targeted input activity
manipulations, only inputs from the GPe and NAc were quantified. Inputs from the
NAcCore and NAcLatS were used for normalization because the percentage of total rabieslabeled inputs from these regions was relatively invariant, regardless if injections were
located more medially or laterally in the VTA7, or if a drug of abuse had been injected (Fig.
1, Extended Data Fig. 1a).
Rabies input tracing with two-day LMS procedure

Author Manuscript

To examine the relationship between rabies-labeled inputs in the GPe and the locomotor
sensitization to cocaine injections using a two-dose procedure, in DAT-Cre mice, 100 nL of a
1:1 volume mixture of AAV-FLExloxP-TC and AAV-FLExloxP-G was injected into the VTA.
On days 1-2, mice received IP injections of saline and were habituated to an open field
chamber equipped with infrared lasers for motion tracking. On day 3, animals were injected
with one of the following: cocaine (15 mg/kg), amphetamine (1 mg/kg), nicotine (0.5 mg/
kg), or morphine (10 mg/kg) and placed in the same open field chamber. On day 4, RVdG
was injected into the VTA. On day 9, animals were injected with the same dose of the same
drug they had received on day 3, and their locomotion was tracked in the open field.
Animals were sacrificed immediately thereafter. The rabies-labeled inputs in the GPe were
quantified, and normalized to the sum of inputs from the NAcLat and NAcCore.
Axon projection quantification
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Images were obtained and quantified as previously described7, except that three sections
were used for each region and were averaged to obtain the final value. Four brains were used
for each experiment.
Synaptic puncta quantification
Methods for synaptic puncta quantification were adapted from Mosca and Luo42 for use in
mice. To quantify the volume and density of mRuby-labeled puncta from GPe-PV neuron
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termini in the SNr, 300 nL of AAV-FLExloxP-mGFP-2A-synaptophysin-mRuby was injected
into the GPe of PV-Cre mice, and sections were cut at a thickness of 60 μm. Floating
sections were stained using anti-mCherry and anti-GFP antibodies. Sections were imaged on
a Zeiss 510 confocal microscope using a 63× objective, with image stacks containing 30
sections at 0.44 μm intervals using 2× averaging and 2× optical zoom. Three images were
taken of puncta in the SNr as well as in the STN for each brain. Images were analyzed using
Imaris (Bitplane). The surface function was used to obtain the volume of mGFP+ neurites
and mRuby-positive puncta, while the spots function was used to estimate the number of
mRuby puncta. Data from the three slices from the SNr and STN were averaged for each
brain. Measurements from the SNr were normalized to those from the STN.
Quantification of Fos immunostaining
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To quantify integrated neural activity, Cre-dependent AAVs expressing YFP, hM4Di, ChR2,
or Kir2.1 were injected into the GPe of PV-Cre mice and relative activation of VTA-DA
neurons was measured by the ratio of Fos+ neurons in the ventral midbrain that co-stained
with tyrosine hydroxylase (TH) to all Fos+ neurons in the ventral midbrain (Fig. 5g-i).
Animals were sacrificed 90 minutes after the final stimulus (optical stimulation at 20 Hz for
thirty minutes in ChR2-expressing animals, or cocaine/saline injection). When cocaine or
saline was injected in animals expressing hM4Di, CNO was injected thirty minutes prior to
cocaine or saline injection. Animals were transcardially perfused, and brains sectioned on a
vibratome in PBS. Sections were blocked with 10% normal donkey serum (NDS) and 2%
BSA/0.5% triton-X100 in PBS (PBST), then stained with TH and Fos antibodies, in 1%
NDS in PBST at 4 degrees for four nights. Sections were rinsed three times for 30 minutes
each at room temperature, followed by secondary antibody stain in 1% NDS in PBST at 4
degrees for two nights. Sections were then rinsed three times for 30 minutes each, and
mounted on slides. The midbrain from three representative VTA-containing sections were
then imaged on a Zeiss LSM 780 confocal microscope at 20× magnification, and the results
averaged together for each brain. For activation of GPe neurons for Fos immunostaining,
300 nL of AAV-FLExloxP-ChR2 was injected bilaterally into the GPe of PV-Cre mice, and
200 μm, 0.39NA optical fibers were implanted over the VTA. For stimulation, the optical
fiber was connected to a 473 nm laser diode (OEM Laser systems) through an FC/PC
adaptor. Laser output was controlled using a Master-8 pulse stimulation, which delivered 5
ms light pulses at 20 Hz. Light output through the optical fibers was adjusted to 20 mW
using a digital power meter console. Images were taken with a constant exposure time. Cells
with a visually identifiable nuclear label by eye were considered Fos+.
Immunohistochemistry
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The following primary antibodies were used: Rat anti-mCherry, Life Sciences, 1:2000;
chicken anti-GFP, Aves Labs, 1:1000; rabbit anti-TH, Millipore, 1:1000; Goat anti-Fos,
Santa Cruz, 1:500. The following secondary antibodies were used from Jackson
ImmunoResearch at a concentration of 1:250: donkey anti-chicken AlexaFluor488; donkey
anti-goat AlexaFluor488; donkey anti-rat AlexaFluor555; donkey anti-goat AlexaFluor555;
donkey anti-rabbit AlexaFluor647.
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To assess cocaine-induced changes in neuronal activity in vivo, fiber photometry was used43.
750nL of AAV-FLExloxP-GCaMP6f was injected into the GPe of PV-Cre mice, and a 400
μm diameter, 0.48NA optical fiber (Doric Lenses) was implanted at the same location. To
test the effect of GPe-PV neuron stimulation on VTA-DA neuron activity, 300 nL of AAVFLExFRT-bReachES was injected into the GPe, and 750 nL of AAV-FLExloxP-GCaMP6f
was injected into the VTA of DAT-Cre;PV-Flp mice. A 400 μm diameter, 0.48NA optical
fiber was implanted over the VTA, and a 200 μm, 0.39NA fiber (made in-house) was
implanted over the GPe. Implants were secured to the skull with metal screws (Antrin
Miniature Specialists), Metabond (Parkell), and Geristore dental epoxy (DenMat). Mice
were allowed to recover for at least 4 weeks prior to experiments.
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Fiber photometry recordings were made using previously described equipment9. Briefly, 405
nm and 470 nm excitation light was used to excite GCaMP6f at its isosbestic and calciumdependent wavelengths to obtain both a control and calcium signal in the same animal,
respectively. To activate bReachES-expressing GPe-PV neurons, a 594 nm laser was
controlled by a Master-8 pulse stimulation (A.M.P.I) that delivered 5 ms pulses at 40 Hz.
Light output through the optical fibers was adjusted to 10 mW using a digital power meter
console (Thorlabs). Light was manually switched on at 10 minutes and off at 20 minutes.
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All data analysis was performed in MATLAB. Signals were first motion corrected by
subtracting the least squares best fit of the control trace to the calcium signal. Data points
containing large motion artifacts were then manually removed. To assess neural activity, the
median absolute deviation (MAD) was calculated across the entire photometry trace during a
given session. We conservatively defined a threshold of 6*MAD to assess bouts of high
neural activity. During each session, we calculated the percentage of time that the
photometry trace was greater than or equal to 6*MAD of the entire trace. For Fig. 2i-k n =
11, and Fig. 5k-m n = 9.
Whole-cell recordings
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Mice were deeply anaesthetized with isoflurane, and coronal midbrain or GPe slices (250
μm) were prepared after intracardial perfusion with ice-cold artificial cerebrospinal fluid
(ACSF) containing (in mM): 230 sucrose, 10 glucose, 25 NaHCO3, 2.5 KCl, 1.2 NaH2PO4,
0.5 CaCl2, 7 MgCl2, and oxygenated with 95% O2/5% CO2. After 60 min of recovery,
slices were transferred to a recording chamber and perfused continuously at 2–4 ml/min with
oxygenated ACSF containing (in mM): 120 NaCl, 10 glucose, 25 NaHCO3, 2.5 KCl, 1.2
NaH2PO4, 2.5 CaCl2, 2.3 MgCl2 at 30 °C. Patch pipettes (3.8-4.4 MΩ) were pulled from
borosilicate glass (G150TF-4; Warner Instruments) and filled with internal solution
containing (in mM): 131 CsCH3SO3, 10 HEPES, 10 glucose, 2 CaCl2, 10 EGTA, 5 MgATP,
0.4 NaGTP, 10 phosphocreatine, 5 QX314, and 0.2% biocytin (pH 7.3, 292 mOsm) for
voltage clamp recordings. For analysis of GPe excitability, the internal solution contained (in
mM): 130 KMeSO3, 9 KCl, 0.1 EGTA, 10 HEPES, 4 Mg-ATP, 0.4 Na-GTP, 7.5
Na2phosphocreatine, adjusted to pH 7.3 with KOH, 290-295 mOsm. Input resistance and
access resistance were monitored continuously throughout each experiment; experiments
were terminated if these changed by >20%.

Nature. Author manuscript; available in PMC 2018 August 01.

Beier et al.

Page 14

Author Manuscript

Labeled neurons were visualized with a 40× water-immersion objective on an upright
fluorescent microscope (BX51WI; Olympus) equipped with infrared-differential
interference contrast video microscopy and epifluorescence (Olympus). ChR2 was
stimulated by flashing 473-nm light (2 ms pulses, 0.1 Hz, 10 mW) through the light path of
the microscope using an ultrahigh-powered light-emitting diode (LED) powered by an LED
driver (Thorlabs) under computer control. The light intensity of the LED was not changed
during the experiments. A dual lamp house adaptor (Olympus) was used to switch between
the fluorescence lamp and LED light source.

Author Manuscript

For monosynaptic connectivity analysis, D-APV (50 μM) and NBQX (10 μM) were added to
block NMDA receptors and AMPA receptors, respectively, and tetrodotoxin (TTX, 1 μM), a
voltage-gated sodium channel antagonist, and 4-aminopyridine (4-AP, 1mM), a potassium
channel antagonist, were added to isolate monosynaptic connections44. The IPSC amplitude
plotted in Fig. 5c only included cells with detectable optically-evoked IPSCs.
For analysis of quantal size and frequency from GPe inputs to SNr neurons, we replaced
calcium in the ACSF with 4 mM SrCl2 to induce asynchronous vesicle release. The
amplitude and frequency of events occurring between 50 ms and 250 ms after the blue light
pulse were recorded. The amplitude of each event was measured from a local baseline
established 5-10 ms before the light pulse. All electrophysiology data were collected using
Axograph software.
Behavioral assays of locomotor sensitization (LMS) and conditioned place preference
(CPP)

Author Manuscript

To test the necessity of GPe-PV neuron activity for the development of LMS or CPP, 300 nL
of AAV-FLExloxP-hM4Di, AAV-FLExloxP-Kir2.1, AAV- FLExloxP-TeTxLc, or AAVFLExloxP-YFP was injected bilaterally into the GPe of PV-Cre animals.
To assay for drug-induced CPP, animals were first tested in a single drug pairing, twochamber CPP test. Each chamber was given either a clear, textured or black, smooth floor.
On the first day, animals were initially placed into the right chamber, and allowed to freely
explore both chambers for thirty minutes (pre-test). The second day, animals were salineconditioned to the left side, and the following day, cocaine (or morphine)-conditioned to the
right side. Drug conditioning on the black, smooth or clear, textured floor was counterbalanced across the mice. On the fourth day, animals were again initially placed into the
right chamber, and allowed to explore freely (post-test). For animals injected with CNO, 10
mg/kg CNO was injected thirty minutes before the beginning of the cocaine and saline
pairings.
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The following week, to test LMS, animals were habituated to open field boxes equipped
with motion tracking for two days (receiving saline injections before each session). Animals
were then injected with cocaine (or morphine) immediately before entry into the open-field
boxes, for five consecutive days, for 30 minutes each. For animals injected with CNO, CNO
was injected thirty minutes before the beginning of each session. In Extended Data Fig. 5,
both YFP and hM4Di-expressing animals were given CNO 30 minutes prior to morphine
injection.
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To inhibit GPe-PV→midbrain neurons, 500 nL of CAV2-FLExloxP-Flp was injected into the
SNr, and 300 nL of AAV-FLExFRT-Kir2.1 was injected into the GPe of PV-Cre mice. All
injections were bilateral. Animals were tested 2 weeks later.

Author Manuscript

To inhibit GPe-PV terminals in the midbrain, animals were injected with 300 nL of AAVFLExloxP-YFP or AAV-FLExloxP-hM4Di in the GPe, and a bilateral cannula guide (C235G,
26GA, C/C distance 1.8 mm, 5 mm pedestal, cut 3.5 mm below pedestal, custom specified
for mouse bilateral VTA coordinates, Plastics One) was implanted over the VTA
(coordinates AP −3.5, ML 0.9, DV −3.13). 2 skull screws were implanted for headcap
stability, and headcaps were sealed with Metabond and Geristore. CNO microspheres were
synthesized to enable slow release of CNO after a single infusion. Degradex PLGA CNO
microspheres were custom ordered from Phosphorex (Hopkinton, MA). Beads of target
mean diameter = 1 μm were dissolved in 0.5% trehalose at a concentration of 5 mg
microsphere/mL. The estimated CNO loading efficiency was 5%, the estimated burst release
was 50%, and the estimated release time was 7 days. The target concentration of CNO
release at a steady state was 100pg/hr23, 45.
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On day 1 of the behavioral protocols, animals were given an IP saline injection. On day 2,
one hour prior to locomotor testing, all cannula guides were pierced with a dummy infuser
(C235I, 33GA, project 1.5 MM past guide), and mice were given an IP saline injection one
hour later. On day 3, CNO microspheres were infused one hour prior to locomotor testing,
250 nL per side at 250 nL/min, and mice were given an IP saline injection one hour later and
tested for effects on basal locomotion. On days 3-6 (starting the same afternoon), animals
were run through the CPP protocol and the LMS protocol on days 6-10. We then waited a
week for CNO washout, and repeated the standard CPP and LMS procedures without
subsequent infusions in hM4Di-expressing animals.
For manipulations of SNr-GABA neurons, 500 nL of AAV-FLExloxP-hM3Dq was injected
bilaterally into the SNr of GAD2-Cre mice, or 500 nL of AAV-FLExloxP-hM4Di was
injected into the SNr and 300 nL of AAV-FLExFRT-Kir2.1 was injected into the GPe of
GAD2-Cre;PV-Flp animals. All injections were bilateral.
Data analyses and statistics
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All statistics were calculated using GraphPad Prism 7 software. Statistical significance was
assessed by paired t-tests with the exception of Fig. 2n, where a two-way ANOVA was used,
and Fig. 2k and 5m where a one-way ANOVA was used with the Geisser-Greenhouse
correction followed by post-hoc Wilcoxon matched-pairs signed rank tests. Dot plots
presented throughout the manuscript include a horizontal line representing the mean value
for each group. In Fig. 1 and Extended Data Fig. 1, the length of each bar represents the
mean. Error bars represent SEM throughout. For all figures, ns p > 0.05, * p ≤ 0.05, ** p ≤
0.01, *** p ≤ 0.001, **** p ≤ 0.0001.
Data availability
Numerical data for each figure is included with the manuscript as source data. All other data
will be available from the authors upon reasonable request.
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Extended Data
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Extended Data Figure 1. Changes to VTA-DA inputs induced by drugs of abuse

a, Quantification of monosynaptic inputs to VTA-DA neurons labeled in animals receiving
single dose administration of either cocaine, amphetamine, nicotine, morphine, saline, or
fluoxetine one day prior to injection of RVdG into the VTA. Data were combined to generate
Fig. 1c. b, Sample images of GPe neurons labeled by RVdG and co-stained for PV. Pie
graph shows proportion of labeled cells that co-stained for PV. c, Sample images of
NAcMedS neurons labeled by RVdG in DAT-Cre;D1-tdTomato mice. Pie graph shows
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proportion of labeled cells that were D1+ as defined by presence of tdTomato (scale bars =
50 μm).
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Extended Data Figure 2. Axonal projections of GPe-PV neurons

a, AAV-FLExloxP-mGFP was injected into the GPe of PV-Cre animals, and mGFP+ axons
were quantified throughout the brain. b, Quantification of fraction of mGFP+ axons in the
indicated brain regions. c, Sample image of mGFP+ axons in the ventral midbrain (scale bar
= 500 μm). d, Quantification of fraction of mGFP+ axons in the indicated ventral midbrain
brain regions. The schematics of the mouse brain in this figure were adapted from ref. 33.
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Extended Data Figure 3. Inhibition of GPe-PV neuron activity modestly affects cocaine-induced
locomotion
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a, Cre-dependent AAVs expressing YFP, hM4Di, Kir2.1, or TeTxLc were injected into the
GPe of PV-Cre animals. b, Quantification of effects of CNO on basal locomotion in animals
expressing YFP or hM4Di (compared to YFP + saline: YFP + CNO, p = 0.36; hM4Di +
CNO, p = 0.59). c, Quantification of basal locomotion during GPe-PV neuron inhibition
(hM4Di, p = 0.54; Kir2.1, p = 0.66; TeTxLc, p = 0.27). d, Quantification of cocaine-induced
locomotion during GPe-PV neuron inhibition (hM4Di, p = 0.37; Kir2.1, p = 0.12; TeTxLc, p
= 0.002). The schematics of the mouse brain in this figure were adapted from ref. 33.
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Extended Data Figure 4. Labeled GPe inputs to the VTA correlated with LMS
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a, AAV-FLExloxP-TC and AAV-FLExloxP-G were injected into the VTA of DAT-Cre mice.
Eleven days later, animals were habituated for two days to an open field chamber, and given
a drug injection the following day. RVdG was injected one day after the drug. Five days after
RVdG injection, the animal was given a second injection of the same drug in the open field.
b, Normalized labeled GPe inputs plotted against the relative locomotion in session 2 vs.
session 1 for cocaine (n = 34), amphetamine (n = 5), nicotine (n = 5), and morphine (n = 5).
Regression line is plotted for all drugs combined. c-e, Labeled GPe inputs after a single dose
of cocaine significantly correlated with LMS (c), but not total locomotion after the first (d)
or second (e) dose of cocaine. f-h, Plots of labeled GPe inputs vs. LMS for (f) amphetamine
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(1 mg/kg), (g) nicotine (0.5 mg/kg), or (h) morphine (10 mg/kg). The schematics of the
mouse brain in this figure were adapted from ref. 33.
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Extended Data Figure 5. Inhibition of the GPe prevents morphine LMS and CPP

a, A Cre-dependent AAV expressing either YFP or hM4Di was injected into the GPe of PVCre animals. b, c, Quantification of LMS (b; p = 0.022) and CPP (c; p = 0.0005) in animals
in which YFP or hM4Di (activated by CNO) were expressed in GPe-PV neurons. The
schematics of the mouse brain in this figure were adapted from ref. 33.
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Extended Data Figure 6. Inhibition of GPe-PV→midbrain projection neurons blocks cocaine
CPP and LMS
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a, CAV-FLExloxP-Flp was injected into the ventral midbrain, and AAV-FLExFRT-Kir2.1 or
AAV-FLExFRT-YFP was injected into the GPe of PV-Cre mice. b, c, Quantification of LMS
(b; p = 0.019) and CPP (c; p = 0.0067) in animals in which YFP or Kir2.1 were expressed in
GPe-PV neurons projecting to the ventral midbrain. The schematics of the mouse brain in
this figure were adapted from ref. 33.
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Extended Data Figure 7. GPe-PV→midbrain neurons collateralize to multiple subcortical
targets

a, CAV-FLExloxP-Flp was injected into the ventral midbrain, and AAV-FLExFRT-mGFP was
injected into in the GPe of PV-Cre mice. b, Representative image of mGFP+ collaterals in
the thalamus and subthalamic nucleus (STN) (scale bar = 500 μm). c, Quantification of
projection fraction of collaterals to indicated target regions. The schematics of the mouse
brain in this figure were adapted from ref. 33.
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Extended Data Figure 8. DA neuron activity is required for the development of LMS and CPP

a, Breeding scheme for experiments. LSL = loxP stop loxP. b, c, Quantification of LMS (b;
p = 0.001) and CPP (c; p = 0.005) in control animals or animals expressing hM4Di in DA
neurons receiving CNO.
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Extended Data Figure 9. Map of anatomical location of ventral midbrain cells from which whole
cell recordings were made
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Individual dots indicate location of cells in which ChR2-evoked IPSCs due to ChR2
expression in GPe-PV neurons could be detected (connected) or not (not connected) in
NAcLat-projecting (a) or NAcMed-projecting (b) VTA-DA neurons, and SNr-GABA (c) or
VTA-GABA (d) cells. The schematics of the mouse brain in this figure were adapted from
ref. 33.
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Extended Data Figure 10. GPe-PV neurons mediate their effects through SNr-GABA neurons

a, Procedure to test LMS and CPP during SNr-GABA activation. b, c, Activating SNrGABA neurons with CNO prevented LMS (b; p = 0.010) and CPP (c; p = 0.015). d,
Injection strategy to test if SNr-GABA neurons are downstream of GPe-PV neurons. e, f,
While expression of Kir2.1 in GPe-PV neurons prevented LMS and CPP, this suppression
was overcome by concurrent inhibition of SNr-GABA neurons (e; p = 0.035, f; p = 0.036).
The schematics of the mouse brain in this figure were adapted from ref. 33.
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Figure 1. Cocaine-induced changes to VTA neuron inputs
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a, Strategy for labeling inputs to VTA-DA neurons. b, Fraction of total GFP+ inputs from
each site relative to total quantified inputs. Highlighted regions represent p < 0.05 (p = 0.04,
0.04, 0.02, 0.02 for EAM, EP, GPe, and ZI, respectively). c, Combined data for
administration of drug of abuse (n = 4, 5, 5, 4 for cocaine, amphetamine, morphine, and
nicotine, respectively) or control (saline, n = 4; fluoxetine, n = 3: p = 0.005, 0.007, 0.05,
0.05 for GPe, MHb, NAcMedS, and Ant. Ctx., respectively). d, e, Strategy (d) and
quantification (e) of labeling inputs to ventral midbrain GABA neurons (GPe, p = 0.01). In
this and subsequent figures, unless otherwise noted, all statistical analyses used paired ttests, and error bars represent SEM. See Methods for abbreviations of anatomical terms. The
schematics of the mouse brain in this figure were adapted from ref. 33.
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Figure 2. Cocaine triggers increase in GPe-PV neuron activity and excitability
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a, AAV-FLExloxP-mGFP-2A-synaptophysin-mRuby was injected in GPe of PV-Cre mice to
quantify mRuby+ puncta in SNr. b, mGFP+ neurites and mRuby+ puncta from GPe-PV
neurons in SNr (scale = 10 μm). c, d, No change in density (c; p = 0.99) or volume (d; p =
0.76) of mRuby puncta was observed. e, AAV-FLExFRT-ChR2 was injected into GPe of PVFlp mice, and recordings conducted from SNr-GABA neurons in slices from cocaine or
saline-treated animals. f, Trace from SNr neuron highlighting the time window for analysis.
g, h, No change in quantal IPSC amplitude (g; p = 0.94) or frequency (h; p = 0.94) was
observed. i, AAV-FLExloxP-GCaMP6f was injected into GPe of PV-Cre animals to measure
PV neuron activity using fiber photometry. j, Traces showing ΔF/F following the first saline,
cocaine, and second saline injections. Red = activity threshold of six times the median
absolute deviation. k, Percent time activity surpassed threshold (one-way ANOVA, p =
0.018; post-hoc tests day 1 vs. 2, p = 0.17; day 1 vs. 3, p = 0.0049). l, AAV-FLExloxP-GFP
was injected into GPe of PV-Cre mice, and recordings made from GFP+ cells. m, Traces
from depolarizing current injections. n, Frequency of action potentials over range of current
steps (p < 0.0001 for saline vs. cocaine, two-way ANOVA). For this and all subsequent
figures, ns p > 0.05, * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001. Dot plots
include horizontal line representing mean. The schematics of the mouse brain in this figure
were adapted from ref. 33.
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Figure 3. Bidirectional modulation of rabies labeling by activity manipulations
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a, A mixture of AAV-FLExloxP-TC and AAV-FLExloxP-G was injected into VTA while an
AAV expressing a Flp-dependent YFP, hM4Di, Kir2.1, or hM3Dq was injected into GPe. b,
Image of rabies labeling in GPe (scale = 1 mm). c, Experimental strategy for d-e. d,
Quantification of labeled inputs in GPe when GPe was manipulated. y-axis = labeled GPe
inputs/(NAcLat + NAcCore inputs). Combined controls (uninjected and YFP) were assigned
a value of 1. GPe inhibition reduced (hM4Di, p = 0.004; Kir2.1, p < 0.0001) while activation
increased (hM3Dq, p = 0.016) labeled inputs. e, Quantification of labeled inputs in
NAcMedS following GPe activity manipulations (hM4Di, p = 0.98; Kir2.1, p = 0.90;
hM3Dq, p = 0.88). f, Experimental strategy for g-h. g, NAcMedS-D1 inhibition had no
effect on labeling of GPe inputs (hM4Di, p = 0.13; Kir2.1, p = 0.65) while activation
increased labeling (hM3Dq, p < 0.001). h, NAcMedS-D1 inhibition decreased (hM4Di, p =
0.02; Kir2.1, p = 0.03) while activation increased (hM3Dq, p = 0.007) labeling of NAcMedS
inputs. The schematics of the mouse brain in this figure were adapted from ref. 33.
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Figure 4. GPe-PV neuron activity is required for cocaine-induced LMS and CPP
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a, Cre-dependent AAVs were injected into GPe of PV-Cre animals. b, Plot of locomotor
activity for a single animal. c, GPe-PV inhibition blocked cocaine-induced LMS (hM4Di, p
= 0.0002; Kir2.1, p = 0.007; TeTxLc, p = 0.008). d, Procedure to test CPP during GPe-PV
inhibition. e, Trace from YFP animal during post-test. f, GPe-PV inhibition prevented CPP
(hM4Di, p = 0.019; Kir2.1, p = 0.030; TeTxLc, p = 0.029). g, Slow-release CNO
microspheres were injected into ventral midbrain in animals expressing hM4Di or YFP in
GPe-PV neurons. h, i, Both LMS (h; p = 0.0005) and CPP (i; p = 0.0094) were blocked in
hM4Di-expressing animals. When tested again after CNO washout, these same animals
developed LMS (h; p = 0.047) and CPP (i; p = 0.0078). The schematics of the mouse brain
in this figure were adapted from ref. 33.
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Figure 5. GPe-PV neurons disinhibit VTA-DA neurons
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a, AAV-FLExFRT-ChR2 was injected into GPe, AAV-FLExloxP-GFP injected in VTA, and
retrobeads injected into NAcLatS or NAcMedS of DAT-Cre;PV-Flp or GAD2-Cre;PV-Flp
mice. Whole-cell recordings were made from identified midbrain neurons in acute slices. b,
Example light-evoked IPSCs. c, Quantification of percent connectivity and IPSC amplitude
for each cell type. d, AAV-FLExloxP-TC66T and AAV-FLExloxP-G were injected into VTA
of DAT-Cre mice, followed two weeks later by RVdG. e, Sample labeling of midbrain
section (scale = 1 mm). f, Quantification of labeled local inhibitory inputs. g, Cre-dependent
AAVs expressing YFP, hM4Di, Kir2.1, or ChR2 were injected into GPe of PV-Cre mice
followed by quantification of Fos labeling. h, i, Sections of ventral midbrain showing Fos
labeling (green) and tyrosine hydroxylase (TH) labeling (magenta) in animals receiving
cocaine injections and expressing YFP (h) or hM4Di (i) in GPe. Arrows indicate Fos+
neurons co-expressing TH (scale = 200 μm). j, Quantification of activated DA neurons (Fos+
TH+) relative to all activated ventral midbrain neurons (Fos+) (cocaine-YFP, p = 0.029;
ChR2, p < 0.0001). k, Flp-dependent bReachES was injected in GPe and a Cre-dependent
GCaMP6f was injected in VTA of DAT-Cre;PV-Flp mice. l, Fiber photometry traces during
consecutive 10 min epochs. m, VTA-DA neurons were more active during light-on than
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light-off (one-way ANOVA, p = 0.014; post-hoc tests 0-10 vs. 10-20 min, p = 0.008; 10-20
vs. 20-30 min, p = 0.039). n, Proposed circuit diagram before and after cocaine. Size of cell
body and arrows represent activity strength. The schematics of the mouse brain in this figure
were adapted from ref. 33.
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